CORT
NASDAQ
US
Corcept Therapeutics Incorporated - Common Stock
$42,49
▲ +$0,51
(+1,21%)
Hac. 1.5M
11
Kalite Puanı
ok
Derin İnceleme
2/5
ok
Gelir ✓
Net Gelir ✓
>IPO ✗
Piy. Değ.
$3.7B
P/E
34,5
ROE
16,1%
Marj
14,3%
D/E
0,00
Beta
0,18
52W
$49–$117
Wall Street Uzlaşısı
12 analist · Nis 20262
Güçlü Al
7
Al
3
Tut
0
Sat
0
Güçlü Sat
75,0%
Alım Notu
Fiyat Grafiği
Benzer Hisseler
AXSM
Axsome Therapeutics Inc
$9.2B
BLTE
Belite Bio Inc
$5.6B
TERN
Terns Pharmaceuticals Inc
$4.3B
LGND
Ligand Pharmaceuticals Inc
P/E 76,6
$3.7B
AMRX
Amneal Pharmaceuticals Inc
P/E 671,4
$4.0B
CRNX
Crinetics Pharmaceuticals Inc
$4.4B
INDV
Indivior Pharmaceuticals, Inc
P/E 35,8
$4.5B
GPCR
Structure Therapeutics Inc
$4.2B
EWTX
Edgewise Therapeutics Inc
$2.6B
Kazançlar
Geçme oranı: 75,0%| Çeyrek | EPS Tahmin | EPS Gerçek | Sürpriz |
|---|---|---|---|
| Ara 2025 | $0,31 | $0,20 | $-0,11 |
| Eyl 2025 | $0,14 | $0,16 | +$0,02 |
| Haz 2025 | $0,19 | $0,29 | +$0,10 |
| Mar 2025 | $0,15 | $0,17 | +$0,02 |
Çeyreklik Gelir ve Kazanç
| Çeyrek | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Gelir | — | $181.9M | $157.2M | $194.4M | $207.6M | $202.1M |
| Net Gelir | — | $30.7M | $20.5M | $35.1M | $19.7M | $24.3M |
Temel Gösterge Trendi
| Metrik | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 20.3% | 20.3% | 20.3% | 20.3% | 16.1% | 16.1% |
| P/E (TTM) | 58.24 | 55.72 | 67.13 | 57.92 | 78.80 | 34.50 |
| Net Margin | 18.1% | 18.7% | 18.7% | 18.7% | 14.3% | 14.3% |
| Gross Margin | 98.2% | 98.4% | 98.4% | 98.4% | 98.2% | 98.2% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 3.06 | 3.06 | 3.06 | 3.06 | 3.14 | 3.14 |
Temel Oranlar
ROA (TTM)
12,8%
P/S (TTM)
4,94
P/B
7,8
EPS (TTM)
$0,89
CF/Share
$0,81
Gelir Büyümesi 3Y
+22,6%
52W High
$117,33
52W Low
$49,00
$49,00
52 Haftalık Aralık
$117,33
Finansal Sağlık
Serbest Nakit Akışı
$38.4M
Net Borç
-$114.4M
Nakit
$120.5M
Toplam Borç
$6.1M
Tarih itibarıyla Ara 31, 2025
Як CORT виглядає на тлі конкурентів у Pharmaceuticals?
Група порівняння: Mid-cap Pharmaceuticals ($2B+) · 25 компаній
Оцінка CORT vs аналоги Pharmaceuticals
P/E
34,5
▲
13%
üstünde
emsaller
(30,7)
vs Emsaller
vs Sektör
Düşük değerlenmiş
P/S
4,9
▼
27%
altında
emsaller
(6,7)
vs Emsaller
vs Sektör
Daha pahalı
P/B
7,8
▲
49%
üstünde
emsaller
(5,2)
vs Emsaller
vs Sektör
Daha pahalı
Дивідендна дохідність
—
▼
0%
altında
emsaller
(3,1%)
vs Emsaller
vs Sektör
Düşük getiri
Прибутковість CORT vs аналоги Pharmaceuticals
ROE
16,1%
▲
162%
üstünde
emsaller
(-26,1%)
vs Emsaller
vs Sektör
En üst seviye
Net margin
14,3%
▲
1088%
üstünde
emsaller
(-1,5%)
vs Emsaller
vs Sektör
Ortalamanın altında
Валова маржа
98,2%
▲
10%
üstünde
emsaller
(88,9%)
vs Emsaller
vs Sektör
Uyumlu
ROA
12,8%
▲
236%
üstünde
emsaller
(-9,5%)
vs Emsaller
vs Sektör
En üst seviye
Фінансове здоровʼя CORT vs аналоги Pharmaceuticals
D/E ratio
0,0
▼
100%
altında
emsaller
(27,4)
vs Emsaller
vs Sektör
Düşük borç
Поточна ліквідність
3,1
▼
10%
altında
emsaller
(3,5)
vs Emsaller
vs Sektör
Uyumlu
Beta
0,2
▼
70%
altında
emsaller
(0,6)
vs Emsaller
vs Sektör
Daha oynak
Радар фундаменталів CORT
CORT
Emsal medyanı
Endüstri
CORT прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
CORT vs аналоги: ключові метрики
İçeriden İşlemler
NeutralAlımlar
0
Satımlar
0
BELANOFF JOSEPH K
Chief Executive Officer · Mar 25
26198 shs
GUYER WILLIAM
Officer · Mar 20
11767 shs
GUYER WILLIAM
Officer · Mar 20
11767 shs
WILSON JAMES N
Director · Mar 20
4000 shs
BAKER GEORGE LEONARD JR.
Director · Mar 17
100000 shs
MAHONEY DAVID L
Director · Mar 13
30000 shs
WILSON JAMES N
Director · Mar 13
28000 shs
MAHONEY DAVID L
Director · Mar 13
24531 shs
GUYER WILLIAM
Officer · Mar 04
8233 shs
GUYER WILLIAM
Officer · Mar 04
8233 shs
Son 90 gün
En Büyük Sahipler
İlk 5: 36,09%Blackrock Inc.
11,34%
$453.5M
Vanguard Group Inc
8,93%
$357.0M
Ingalls & Snyder LLC
6,76%
$270.5M
Renaissance Technologies, L…
5,41%
$216.5M
Parallel Advisors, LLC
3,65%
$145.9M
Tarih itibarıyla Ara 31, 2025